A detailed history of Ameritas Investment Partners, Inc. transactions in Cerus Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 17,500 shares of CERS stock, worth $30,625. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,500
Previous 17,500 -0.0%
Holding current value
$30,625
Previous $33,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.07 $6,511 - $13,326
4,341 Added 32.99%
17,500 $28,000
Q4 2021

Feb 11, 2022

SELL
$5.97 - $7.93 $6,895 - $9,159
-1,155 Reduced 8.07%
13,159 $90,000
Q2 2020

Aug 05, 2020

BUY
$4.5 - $7.02 $7,938 - $12,383
1,764 Added 14.06%
14,314 $94,000
Q1 2020

May 13, 2020

BUY
$2.87 - $5.49 $5,200 - $9,947
1,812 Added 16.87%
12,550 $58,000
Q1 2018

May 15, 2018

BUY
$3.56 - $5.74 $10,007 - $16,135
2,811 Added 35.46%
10,738 $59,000
Q2 2017

Aug 15, 2017

BUY
N/A
7,927
7,927 $20,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $310M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.